Brazilian study aims to prove RSV shot for pregnant women shields newborns
NCT ID NCT07445763
Summary
This study aims to measure how well a vaccine given to pregnant women protects their babies from severe Respiratory Syncytial Virus (RSV) illness during their first months of life. Researchers will follow 5000 infants in Brazil, comparing those whose mothers received the vaccine to those who did not, to see if vaccinated mothers' babies have fewer hospital visits for RSV. The study will track babies who get sick with respiratory symptoms, testing them for RSV to determine the vaccine's real-world effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.